Clinical outcomes and quality of life in recipients of livers donated after cardiac death

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Parikh, Neehar D ^a,b   Skaro, Anton I ^b,c   Ladner, Daniela P ^b,c   Lyuksemburg, Vadim ^b   Cahan, Joshua G ^b   Daud, Amna ^b,c   Butt, Zeeshan ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILE DUCT DISEASE; BRAIN DEATH; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISTRESS SYNDROME; DONATION AFTER BRAIN DEATH; DONATION AFTER CARDIAC DEATH; FEMALE; FULMINANT HEPATIC FAILURE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEART DEATH; HEPATITIS C; HUMAN; HUMAN TISSUE; ISCHEMIC CHOLANGIOPATHY; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; ORGAN DONOR; OUTCOME ASSESSMENT; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SLEEP QUALITY;

EID: 84928143339     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/680316     Document Type: Article

References (22)

1. S. Tome, J. T. Wells, A. Said, and M. R. Lucey, "Quality of life after liver transplantation. A systematic review, " Journal of Hepatology, vol. 48, no. 4, pp. 567-577, 2008.
2. Based on OPTN data as of January 1, 2011.
3. K. Washburn, E. Pomfret, and J. Roberts, "Liver allocation and distribution: possible next steps, " Liver Transplantation, vol. 17, no. 9, pp. 1005-1012, 2011.
4. T. J. Shafer, D. Wagner, J. Chessare et al., "US organ donation breakthrough collaborative increases organ donation, " Critical Care Nursing Quarterly, vol. 31, no. 3, pp. 190-210, 2008.
5. E. S. Orman, A. S. Barritt, S. B. Wheeler, and P. H. Hayashi, "Declining liver utilization for transplantation in the United States and the impact of donation after cardiac death, " Liver Transplantation, vol. 19, no. 1, pp. 59-68, 2013.
6. D. P. Foley, L. A. Fernandez, G. Leverson et al., "Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center, " Annals of Surgery, vol. 253, no. 4, pp. 817-825, 2011.
7. A. I. Skaro, C. L. Jay, T. B. Baker et al., "The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story, " Surgery, vol. 146, no. 4, pp. 543-553, 2009.
8. O. Detry, V. Donckier, V. Lucidi et al., "Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007, " Transplant International, vol. 23, no. 6, pp. 611-618, 2010.
9. C. Jay, D. Ladner, E. Wang et al., "A comprehensive risk assessment of mortality following donation after cardiac death liver transplant-an analysis of the national registry, " Journal of Hepatology, vol. 55, no. 4, pp. 808-813, 2011.
10. C. L. Jay, V. Lyuksemburg, D. P. Ladner et al., "Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis, " Annals of Surgery, vol. 253, no. 2, pp. 259-264, 2011.
11. M. L. Volk and M. Hagan, "Organ quality and quality of life after liver transplantation, " Liver Transplantation, vol. 17, no. 12, pp. 1443-1447, 2011.
12. M. E. de Vera, R. Lopez-Solis, I. Dvorchik et al., "Liver transplantation using donation after cardiac death donors: longterm follow-up from a single center, " American Journal of Transplantation, vol. 9, no. 4, pp. 773-781, 2009.
13. Centers for Disease Control and Prevention, Measuring Healthy Days, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 2000.
14. C. L. Jay, V. Lyuksemburg, R. Kang et al., "The increased costs of donation after cardiac death liver transplantation: caveat emptor, " Annals of Surgery, vol. 251, no. 4, pp. 743-748, 2010.
15. F. Kanwal, B. M. R. Spiegel, R. D. Hays et al., "Prospective validation of the short formliver disease quality of life instrument, " Alimentary Pharmacology and Therapeutics, vol. 28, no. 9, pp. 1088-1101, 2008.
16. C. B. Taner, I. G. Bulatao, D. L. Willingham et al., "Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors, " Liver Transplantation, vol. 18, no. 1, pp. 100-111, 2012.
17. S. Feng, N. P. Goodrich, J. L. Bragg-Greshamet al., "Characteristics associated with liver graft failure: the concept of a donor risk index, "The American Journal of Transplantation, vol. 6, no. 4, pp. 783-790, 2006.
18. S. Saab, V. Ng, C. Landaverde et al., "Development of a diseasespecific questionnaire to measure health-related quality of life in liver transplant recipients, " Liver Transplantation, vol. 17, no. 5, pp. 567-579, 2011.
19. M. L. Volk, R. S. Tocco, S. J. Pelletier, B. J. Zikmund-Fisher, and A. S. F. Lok, "Patient decision making about organ quality in liver transplantation, " Liver Transplantation, vol. 17, no. 12, pp. 1387-1393, 2011.
20. C. Fondevila, A. J. Hessheimer, M.-H. J. Maathuis et al., "Superior preservation ofDCDlivers with continuous normothermic perfusion, " Annals of Surgery, vol. 254, no. 6, pp. 1000-1007, 2011.
21. H. Xu, T. Berendsen, K. Kim et al., "Excorporeal normothermic machine perfusion resuscitates pig DCD livers with extended warm ischemia, " Journal of Surgical Research, vol. 173, no. 2, pp. e83-e88, 2012.
22. M. U. Boehnert, J. C. Yeung, F. Bazerbachi et al., "Normothermic acellular ex vivo liver perfusion reduces liver and bile duct injury of pig livers retrieved after cardiac death, " American Journal of Transplantation, vol. 13, no. 6, pp. 1441-1449, 2013.